- Home
- SYRE vs MFA Comparison
SYRE vs MFA Comparison
Compare SYRE & MFA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SYRE
- MFA
- Stock Information
- Founded
- SYRE 2013
- MFA 1997
- Country
- SYRE United States
- MFA United States
- Employees
- SYRE N/A
- MFA N/A
- Industry
- SYRE Biotechnology: Pharmaceutical Preparations
- MFA Real Estate Investment Trusts
- Sector
- SYRE Health Care
- MFA Real Estate
- Exchange
- SYRE Nasdaq
- MFA Nasdaq
- Market Cap
- SYRE 1.2B
- MFA 1.1B
- IPO Year
- SYRE 2016
- MFA N/A
- Fundamental
- Price
- SYRE $16.14
- MFA $10.27
- Analyst Decision
- SYRE Strong Buy
- MFA Buy
- Analyst Count
- SYRE 8
- MFA 5
- Target Price
- SYRE $51.50
- MFA $13.20
- AVG Volume (30 Days)
- SYRE 661.8K
- MFA 1.1M
- Earning Date
- SYRE 05-08-2025
- MFA 05-05-2025
- Dividend Yield
- SYRE N/A
- MFA 13.97%
- EPS Growth
- SYRE N/A
- MFA 78.26
- EPS
- SYRE N/A
- MFA 0.82
- Revenue
- SYRE N/A
- MFA $279,608,000.00
- Revenue This Year
- SYRE N/A
- MFA N/A
- Revenue Next Year
- SYRE N/A
- MFA $8.97
- P/E Ratio
- SYRE N/A
- MFA $12.57
- Revenue Growth
- SYRE N/A
- MFA 19.47
- 52 Week Low
- SYRE $16.13
- MFA $9.36
- 52 Week High
- SYRE $40.84
- MFA $13.45
- Technical
- Relative Strength Index (RSI)
- SYRE 35.24
- MFA 35.41
- Support Level
- SYRE $16.71
- MFA $10.64
- Resistance Level
- SYRE $18.28
- MFA $10.89
- Average True Range (ATR)
- SYRE 1.21
- MFA 0.21
- MACD
- SYRE -0.03
- MFA -0.06
- Stochastic Oscillator
- SYRE 0.15
- MFA 29.21
About SYRE Spyre Therapeutics Inc.
Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.
About MFA MFA Financial Inc.
MFA Financial Inc is a specialty finance company that invests in and finances residential mortgage assets. Its principal business objective is to deliver shareholder value through the generation of distributable income and through asset performance linked to residential mortgage credit fundamentals. The company selectively invests in residential mortgage assets with a focus on credit analysis, projected prepayment rates, interest rate sensitivity and expected return. The company is an internally managed real estate investment trust or REIT.